3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Dec 22, 2022.
-2.5% median (-8.6% mean) 90-day return after 3 previous buys.
The trade is 95.9% of the 10,426 shares held after it.
6 other insiders bought within 30 days.
12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Myers Gail Sharps bought about $8.9K of AQB on Dec 23, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Dec 12, 2022.
+4.1% median (+4.1% mean) 90-day return after 2 previous buys.
The trade is 0.2% of the 426 shares held after it.
6 other insiders bought within 30 days.
12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Myers Gail Sharps bought about $1 of AQB on Dec 22, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 10,000 shares held after it.
6 other insiders bought within 30 days.
12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director St.Clare Christine bought about $7.8K of AQB on Dec 20, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 1,500 shares held after it.
6 other insiders bought within 30 days.
12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sharp Erin S bought about $1.1K of AQB on Dec 19, 2022; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 100.0% of the 130,000 shares held after it.
6 other insiders bought within 30 days.
12 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Sharp Erin S bought about $100.1K of AQB on Dec 19, 2022, the largest insider purchase at the company on our record; 6 other insiders bought within 30 days and 12 funds added in the latest 13F quarter.
67 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AQB planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
AQB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Fidelity Extended Market Index Fund
$42.5K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$25.0K position · as of 2026-06-30
0.0%
Fidelity Series Total Market Index Fund
$7.4K position · as of 2026-05-31
0.0%
Blackstone Alternative Multi-Strategy Fund
$214 position · as of 2026-06-30
0.0%
Fidelity Total Market Index Fund
$4.5K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$398.3K
$394.0K
$306.4K
-98%
n/a
2024
$439.8K
$429.2K
$330.9K
-99%
n/a
2023
$496.7K
$440.2K
$371.1K
-93%
n/a
2022
$553.6K
$497.4K
$394.8K
-65%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 12 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.3M
four quarters, 2023-10-01 to 2024-09-30
Revenue, TTM AQB
FY Dec 2025
$1.3M
FY Dec 2024
$1.3M
FY Dec 2023
$2.5M
FY Dec 2022
$3.1M
FY Dec 2021
$1.2M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
$47.8K
At each fiscal year end
Single quarter
Net margin, TTM
-1,458%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM AQB
FY Dec 2025
-1,469%
FY Dec 2024
-11,855%
FY Dec 2023
-1,115%
FY Dec 2022
-706.3%
FY Dec 2021
-1,900%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
-$10.1M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM AQB
FY Dec 2025
-$11.7M
FY Dec 2024
-$16.8M
FY Dec 2023
-$93.1M
FY Dec 2022
-$88.5M
FY Dec 2021
-$26.2M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
-$1.4M
Sep 2024
-$4.7M
At each fiscal year end
Single quarter
Debt to equity
4.16x
long-term 2026-03-31 plus current 2025-09-30 (9 months older than the period end); equity 2026-06-30
Debt to equity AQB
FY Dec 2025
n/a
FY Dec 2024
0.21x
FY Dec 2023
0.03x
FY Dec 2022
0.05x
FY Dec 2021
0.04x
Jun 2026
4.16x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
0.65x
Jun 2025
0.62x
Mar 2025
0.06x
Dec 2024
0.21x
Sep 2024
0.06x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.61x
TTM operating cash flow over long-term 2026-03-31 plus current 2025-09-30 (9 months older than the period end)
Cash flow to debt AQB
FY Dec 2025
-0.77x
FY Dec 2024
-4.26x
FY Dec 2023
-4.83x
FY Dec 2022
-2.42x
FY Dec 2021
-2.24x
Jun 2026
-0.61x
Mar 2026
-0.63x
Dec 2025
-0.77x
Sep 2025
-0.84x
Jun 2025
-1.06x
Mar 2025
-10.81x
Dec 2024
-4.26x
Sep 2024
-3.28x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-223.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AQB
FY Dec 2025
-265.1%
FY Dec 2024
-165.0%
FY Dec 2023
-15.4%
FY Dec 2022
-10.9%
FY Dec 2021
-13.6%
Jun 2026
-223.4%
Mar 2026
-270.7%
Dec 2025
-265.1%
Sep 2025
-157.5%
Jun 2025
-154.7%
Mar 2025
-161.1%
Dec 2024
-165.0%
Sep 2024
-53.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-95.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AQB
FY Dec 2025
-83.3%
FY Dec 2024
-134.6%
FY Dec 2023
-13.7%
FY Dec 2022
-10.0%
FY Dec 2021
-12.6%
Jun 2026
-95.7%
Mar 2026
-101.3%
Dec 2025
-83.3%
Sep 2025
-124.6%
Jun 2025
-117.5%
Mar 2025
-133.9%
Dec 2024
-134.6%
Sep 2024
-47.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital AQB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed AQB
FY Dec 2025
n/a
FY Dec 2024
-10.1%
FY Dec 2023
-7.4%
FY Dec 2022
-10.6%
FY Dec 2021
-12.8%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
+34.4%
Jun 2025
+32.8%
Mar 2025
-9.4%
Dec 2024
-10.1%
Sep 2024
-19.8%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing AQB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$16.8M
market value at close 2026-10-27 on 2026-08-04 shares, plus long-term 2026-03-31 plus current 2025-09-30 (9 months older than the period end), minus cash 2025-12-31
Enterprise value AQB
FY Dec 2025
$14.5M
FY Dec 2024
$5.4M
FY Dec 2023
$7.8M
FY Dec 2022
$993.6M
FY Dec 2021
$2.9B
Jun 2026
$16.7M
Mar 2026
$15.6M
Dec 2025
$14.5M
Sep 2025
$15.6M
Jun 2025
$10.6M
Mar 2025
$2.4M
Dec 2024
$5.4M
Sep 2024
$9.9M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-181.8%
TTM free cash flow over market value at close 2026-10-27
FCF yield AQB
FY Dec 2025
-323.6%
FY Dec 2024
-693.9%
FY Dec 2023
-849.4%
FY Dec 2022
-8.1%
FY Dec 2021
-0.9%
Jun 2026
-183.5%
Mar 2026
-232.0%
Dec 2025
-323.6%
Sep 2025
-110.6%
Jun 2025
-417.7%
Mar 2025
-552.8%
Dec 2024
-693.9%
Sep 2024
-505.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing AQB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AQB ranks highest on risk and compliance (46th percentile) and institutional and government (16th), and lowest on profitability (9th), among Other peers.
Profitability
9
Inputs
Return on equity-223.4% · 6 pct, universe of 3,862
Return on assets-95.7% · 11 pct, universe of 4,809
Return on invested capitalthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employedthe filed year and its quarters do not reconcile, so the trailing figure is withheld
Financial health
13
Inputs
Debt to equity4.16x · 5 pct, universe of 3,589
Cash flow to debt-0.61x · 21 pct, universe of 3,314
Growth
13
Inputs
Revenue growth, YoY-21.2% · 13 pct, universe of 4,657
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
16
Inputs
Funds adding, latest quarter12 · 16 pct, universe of 4,970
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
46
Inputs
Short interest, % of float+3.7% · 49 pct, universe of 6,629
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+12.7% · 44 pct, universe of 3,660
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.